Literature DB >> 6361229

Intravenous acyclovir therapy for varicella in immunocompromised children.

H H Balfour.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6361229     DOI: 10.1016/s0022-3476(84)80611-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  9 in total

1.  Acyclovir-induced renal failure: course and risk factors.

Authors:  M G Bianchetti; C Roduit; O H Oetliker
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children.

Authors:  A Y Tan; C J Connett; G J Connett; S C Quek; H K Yap; F Meurice; B W Lee
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

3.  Attenuated varicella virus vaccine in children with renal transplants.

Authors:  I Zamora; J M Simon; M E Da Silva; A I Piqueras
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

4.  Determinants of aciclovir-induced nephrotoxicity in children.

Authors:  Ruth Schreiber; Jacob Wolpin; Gideon Koren
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

5.  Chickenpox pneumonia: experience with antiviral treatment.

Authors:  R N Davidson; W Lynn; P Savage; M H Wansbrough-Jones
Journal:  Thorax       Date:  1988-08       Impact factor: 9.139

6.  Oral BVDU treatment of varicella and zoster in children with cancer.

Authors:  Y Benoit; G Laureys; M J Delbeke; E De Clercq
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

7.  Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions.

Authors:  S E Coffin; R L Hodinka
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  Comparison of techniques and evaluation of three commercial monoclonal antibodies for laboratory diagnosis of varicella-zoster virus in mucocutaneous specimens.

Authors:  J L Pérez; A García; J Niubò; J Salvà; D Podzamczer; R Martín
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

9.  Antiviral therapy of varicella-zoster virus infection in immunocompromised children--a prospective randomized study of aciclovir versus brivudin.

Authors:  M Heidl; H Scholz; W Dörffel; J Hermann
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.